Annual Shareholders Equity
$29.29 M
-$5.86 M-16.66%
31 December 2023
Summary:
TherapeuticsMD annual stockholders equity is currently $29.29 million, with the most recent change of -$5.86 million (-16.66%) on 31 December 2023. During the last 3 years, it has risen by +$153.29 million (+123.62%). TXMD annual shareholders equity is now -77.46% below its all-time high of $129.91 million, reached on 31 December 2017.TXMD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$27.09 M
-$576.00 K-2.08%
30 September 2024
Summary:
TherapeuticsMD quarterly stockholders equity is currently $27.09 million, with the most recent change of -$576.00 thousand (-2.08%) on 30 September 2024. Over the past year, it has dropped by -$958.00 thousand (-3.42%). TXMD quarterly shareholders equity is now -85.22% below its all-time high of $183.37 million, reached on 31 March 2016.TXMD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.7% | -3.4% |
| 3 y3 years | +123.6% | +147.2% |
| 5 y5 years | -70.0% | +227.6% |
TXMD Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.7% | +123.6% | -22.9% | +119.3% |
| 5 y | 5 years | -70.0% | +123.6% | -22.9% | +119.3% |
| alltime | all time | -77.5% | +123.6% | -85.2% | +119.3% |
TherapeuticsMD Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.09 M(-2.1%) |
| June 2024 | - | $27.67 M(-3.5%) |
| Mar 2024 | - | $28.66 M(-2.1%) |
| Dec 2023 | $29.29 M(-16.7%) | $29.29 M(+4.4%) |
| Sept 2023 | - | $28.05 M(-10.1%) |
| June 2023 | - | $31.20 M(-2.6%) |
| Mar 2023 | - | $32.02 M(-8.9%) |
| Dec 2022 | $35.14 M(-137.5%) | $35.14 M(-172.8%) |
| Sept 2022 | - | -$48.27 M(+85.2%) |
| June 2022 | - | -$26.07 M(-81.5%) |
| Mar 2022 | - | -$140.58 M(+50.2%) |
| Dec 2021 | -$93.62 M(-24.5%) | -$93.62 M(+63.2%) |
| Sept 2021 | - | -$57.36 M(+16.9%) |
| June 2021 | - | -$49.07 M(+417.8%) |
| Mar 2021 | - | -$9.48 M(-92.4%) |
| Dec 2020 | -$124.00 M(-1447.7%) | -$124.00 M(+6.9%) |
| Sept 2020 | - | -$116.03 M(+23.3%) |
| June 2020 | - | -$94.09 M(+108.1%) |
| Mar 2020 | - | -$45.21 M(-591.3%) |
| Dec 2019 | $9.20 M(-90.6%) | $9.20 M(-143.3%) |
| Sept 2019 | - | -$21.23 M(-362.3%) |
| June 2019 | - | $8.09 M(-86.7%) |
| Mar 2019 | - | $60.69 M(-37.8%) |
| Dec 2018 | $97.52 M(-24.9%) | $97.52 M(-27.3%) |
| Sept 2018 | - | $134.22 M(+73.1%) |
| June 2018 | - | $77.55 M(-27.7%) |
| Mar 2018 | - | $107.30 M(-17.4%) |
| Dec 2017 | $129.91 M(+1.9%) | $129.91 M(-13.1%) |
| Sept 2017 | - | $149.48 M(+59.7%) |
| June 2017 | - | $93.59 M(-15.2%) |
| Mar 2017 | - | $110.33 M(-13.5%) |
| Dec 2016 | $127.49 M(+102.2%) | $127.49 M(-12.9%) |
| Sept 2016 | - | $146.35 M(-12.5%) |
| June 2016 | - | $167.25 M(-8.8%) |
| Mar 2016 | - | $183.37 M(+190.8%) |
| Dec 2015 | $63.06 M(+30.3%) | $63.06 M(-18.7%) |
| Sept 2015 | - | $77.56 M(+23.1%) |
| June 2015 | - | $63.01 M(-28.2%) |
| Mar 2015 | - | $87.72 M(+81.3%) |
| Dec 2014 | $48.39 M(-11.5%) | $48.39 M(-23.9%) |
| Sept 2014 | - | $63.60 M(+69.7%) |
| June 2014 | - | $37.48 M(-19.8%) |
| Mar 2014 | - | $46.75 M(-14.5%) |
| Dec 2013 | $54.70 M(-3916.8%) | $54.70 M(-11.9%) |
| Sept 2013 | - | $62.09 M(+61.4%) |
| June 2013 | - | $38.47 M(-3.7%) |
| Mar 2013 | - | $39.94 M(-2887.2%) |
| Dec 2012 | -$1.43 M(-16.3%) | -$1.43 M(-66.9%) |
| Sept 2012 | - | -$4.33 M(+515.2%) |
| June 2012 | - | -$704.40 K(-79.0%) |
| Mar 2012 | - | -$3.35 M(+95.8%) |
| Dec 2011 | -$1.71 M | -$1.71 M(+298.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -$429.70 K(+22.4%) |
| June 2011 | - | -$351.20 K(+19.4%) |
| Mar 2011 | - | -$294.10 K(-130.5%) |
| Dec 2010 | $964.40 K(-410.0%) | $964.40 K(-213.8%) |
| Sept 2010 | - | -$847.60 K(-3.4%) |
| June 2010 | - | -$877.50 K(+33.3%) |
| Mar 2010 | - | -$658.40 K(+111.6%) |
| Dec 2009 | -$311.10 K(-1763.6%) | -$311.10 K(-300.3%) |
| Sept 2009 | - | $155.30 K(-733.9%) |
| June 2009 | - | -$24.50 K(+137.9%) |
| Mar 2009 | - | -$10.30 K(-155.1%) |
| Dec 2008 | $18.70 K(-95.5%) | $18.70 K(-38.9%) |
| Sept 2008 | - | $30.60 K(-60.3%) |
| June 2008 | - | $77.10 K(-77.7%) |
| Mar 2008 | - | $345.00 K(-17.4%) |
| Dec 2007 | $417.50 K(-75.3%) | $417.50 K(-78.0%) |
| Sept 2007 | - | $1.90 M(+5.1%) |
| June 2007 | - | $1.81 M(+3.8%) |
| Mar 2007 | - | $1.74 M(+3.2%) |
| Dec 2006 | $1.69 M(+28.4%) | $1.69 M(+5.1%) |
| Sept 2006 | - | $1.61 M(+10.7%) |
| June 2006 | - | $1.45 M(+5.7%) |
| Mar 2006 | - | $1.37 M(+4.4%) |
| Dec 2005 | $1.31 M(+25.0%) | $1.31 M(+5.5%) |
| Sept 2005 | - | $1.25 M(+9.8%) |
| June 2005 | - | $1.13 M(+0.8%) |
| Mar 2005 | - | $1.13 M(+7.0%) |
| Dec 2004 | $1.05 M(+21.4%) | $1.05 M(+8.9%) |
| Sept 2004 | - | $965.10 K(+6.0%) |
| June 2004 | - | $910.30 K(+3.1%) |
| Mar 2004 | - | $882.70 K(+1.9%) |
| Dec 2003 | $866.10 K(+17.6%) | $866.10 K(+4.2%) |
| Sept 2003 | - | $831.30 K(+4.6%) |
| June 2003 | - | $794.80 K(+4.6%) |
| Mar 2003 | - | $759.90 K(+3.2%) |
| Dec 2002 | $736.40 K(+9.6%) | $736.40 K(+7.7%) |
| Sept 2002 | - | $683.70 K(+1.3%) |
| June 2002 | - | $674.70 K(-2.7%) |
| Mar 2002 | - | $693.70 K(+3.2%) |
| Dec 2001 | $672.10 K(+9.8%) | $672.10 K(-3.9%) |
| Sept 2001 | - | $699.40 K(+2.4%) |
| June 2001 | - | $683.10 K(+4.9%) |
| Mar 2001 | - | $651.10 K(+6.4%) |
| Dec 2000 | $612.00 K(+27.4%) | $612.00 K(+12.7%) |
| Sept 2000 | - | $543.00 K(+7.2%) |
| June 2000 | - | $506.30 K(+3.1%) |
| Mar 2000 | - | $491.30 K(+2.3%) |
| Dec 1999 | $480.40 K(+4.9%) | $480.40 K |
| Dec 1998 | $458.10 K(-8.0%) | - |
| Dec 1997 | $497.90 K(-2.5%) | - |
| Dec 1996 | $510.90 K(+16.0%) | - |
| Dec 1995 | $440.50 K(+5.2%) | - |
| Dec 1994 | $418.90 K | - |
FAQ
- What is TherapeuticsMD annual stockholders equity?
- What is the all time high annual shareholders equity for TherapeuticsMD?
- What is TherapeuticsMD annual shareholders equity year-on-year change?
- What is TherapeuticsMD quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for TherapeuticsMD?
- What is TherapeuticsMD quarterly shareholders equity year-on-year change?
What is TherapeuticsMD annual stockholders equity?
The current annual shareholders equity of TXMD is $29.29 M
What is the all time high annual shareholders equity for TherapeuticsMD?
TherapeuticsMD all-time high annual stockholders equity is $129.91 M
What is TherapeuticsMD annual shareholders equity year-on-year change?
Over the past year, TXMD annual stockholders equity has changed by -$5.86 M (-16.66%)
What is TherapeuticsMD quarterly stockholders equity?
The current quarterly shareholders equity of TXMD is $27.09 M
What is the all time high quarterly shareholders equity for TherapeuticsMD?
TherapeuticsMD all-time high quarterly stockholders equity is $183.37 M
What is TherapeuticsMD quarterly shareholders equity year-on-year change?
Over the past year, TXMD quarterly stockholders equity has changed by -$958.00 K (-3.42%)